MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    Comorbid neuropathological features in multiple system atrophy

    H. Sekiya, S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

    Objective: To elucidate the distribution of comorbid neuropathology in multiple system atrophy (MSA) and its clinical correlation. Background: Multiple protein accumulations are often present in…
  • 2022 International Congress

    Impulse control disorder following bilateral pallidothalamic tract focused ultrasound: a case report

    S. Farrand, P. Phal, K. Fernando, A. Evans, R. Blaze (Richmond, Australia)

    Objective: Description of a case of ICD following non-contemporaneous bilateral pallidothalamic focused ultrasound tractotomy. Background: Impulsive and compulsive behaviours in PD are hypothesized to largely…
  • 2022 International Congress

    Progressive Supranuclear Palsy (PSP) Vs Parkinson’s Disease (PD) – Whether Frontal Assessment Battery (FAB) Can Differentiate

    M. Kulsum, D. Das, S. Ananad (Kolkata, India)

    Objective: To find out the ability of the Frontal Assessment Battery (FAB) for quantitative analysis of the executive dysfunction of PSP and PD.To find out…
  • 2022 International Congress

    Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level

    DI. Okhunova, G. Sattarovna, A. Babokhujaev (Tashkent, Uzbekistan)

    Objective: To increase the reliability of the development of dementia in patients with PD by a comparative assessment of clinical scales and neurosteroids Background: Parkinson's…
  • 2022 International Congress

    Impaired behavioral proactive inhibitory control and flexibility in a mouse model of early Parkinson’s disease

    J. Lhost, AM. Ouagazzal, M. Liberge, M. Amalric (Marseille, France)

    Objective: The aim of our study is to address the impact of a moderate nigrostriatal DA lesion induced by 6-hydroxydopamine (6-OHDA) injection into the dorsomedial…
  • 2022 International Congress

    The impact of Parkinson’s disease on multifactorial aspects of attention

    O. Peleg, Z. Ktzir, I. Maidan, D. Levy, A. Mirelman (Tel Aviv, Israel)

    Objective: (1) To characterize the differential effects of PD on the two attentional networks and (2) To examine the ability of attentional measurements differentiate between…
  • 2022 International Congress

    Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

    S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

    Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
  • 2022 International Congress

    Parkinson’s disease and nucleus basalis of Meynert integrity: Cognition and everyday function

    N. Slater, R. Shoorangiz, G. Hall-Mcmaster, A. Harris, L. Livingston, S. Grenfell, K. Clifford, T. Anderson, T. Melzer, J. Dalrymle-Alford (Christchurch, New Zealand)

    Objective: To examine the association between the integrity of the nucleus basalis of Meynert (NBM), cognition and everyday function in Parkinson’s disease (PD). Background: Most…
  • 2022 International Congress

    NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population

    R. Yadav, R. Botta, K. Kumar, BM. Kutty, A. Mahadevan, PK. Pal (Bengaluru, India)

    Objective: To validate NIMHANS Neuropsychological Battery for Elderly( NNB-E) and evaluate cognitive impairment in Parkinson's disease (PD) patients in comparison with healthy controls. Background: Cognitive…
  • 2022 International Congress

    Cognitive profiling in a cohort of Huntington’s disease (HD) patients

    M. Garon, F. Pistonesi, L. Weis, V. Cianci, T. Gandolfi, E. Fiorenzato, C. Tedesco, M. Campagnolo, M. Carecchio, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Marc Chagall’s L’homme à La Tète Renversée (Man with His Head Thrown Back) – An Artistic Depiction of Severe Retrocollis in Neurodegeneration with Brain Iron Accumulation
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley